Literature DB >> 11454789

Serum antibody responses to Clostridium difficile toxin A: predictive and protective?

C Phillips1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11454789      PMCID： PMC1728409          DOI： 10.1136/gut.49.2.167

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.

Authors:  H Stubbe; J Berdoz; J P Kraehenbuhl; B Corthésy
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 2.  Clostridium difficile infection: appendix.

Authors:  M H Wilcox
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

Review 3.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.

Authors:  R Fekety
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

4.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile.

Authors:  J N Mathis; L Pilkinton; D E McMillin
Journal:  Curr Microbiol       Date:  1999-06       Impact factor: 2.188

6.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens.

Authors:  S P Borriello; P Honour
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

8.  Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.

Authors:  S Johnson; D N Gerding; E N Janoff
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

10.  Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.

Authors:  S Johnson; W D Sypura; D N Gerding; S L Ewing; E N Janoff
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441
  10 in total
  1 in total

Review 1.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.